Timothy R. Pearson

This profile gathers the share dealings of Timothy R. Pearson across 3 companies, led by TESARO, Inc., Healthextras Inc and Crescent Biopharma, Inc. Over a trading history stretching from 15 September 2011 to 11 November 2022, the count stands at 11 filings.

Both buying and selling appear: 1 purchase worth €25k, against 2 sales worth €359k. Sales outweigh purchases by €334k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants and 3 option exercises. 2022 to date brings 1 purchase and no sales.

On 14 November 2022 came the latest disclosure, an open-market purchase for €25k in Crescent Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.